联邦制药 (03933.HK)

+ 收藏

现金流量表(联邦制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
起始日期 2024-01-012023-01-012023-01-012022-01-012022-01-01
截止日期 2024-06-302023-12-312023-06-302022-12-312022-06-30
报表类型 合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231
上市前/上市后 上市后上市后上市后上市后上市后
原始币种 人民币人民币人民币人民币人民币
经营活动产生的现金流量
 除税前利润(元) 1,901,702,000.003,344,148,000.001,612,155,000.002,006,766,000.00826,954,000.00
 资产减值准备(元) 20,082,000.0035,663,000.0023,188,000.0067,065,000.00-
 折旧与摊销(元) 305,069,000.00565,648,000.00302,899,000.00552,431,000.00292,240,000.00
 出售物业、厂房及设备的亏损收益(元) 88,770,000.00-21,090,000.0058,417,000.00-13,583,000.0022,066,000.00
 应占联营及合营公司亏损收益(元) 184,000.00-143,000.00-165,000.00189,000.00-
 重估盈余(元) -29,626,000.0012,399,000.00-36,744,000.00-37,730,000.00-308,000.00
 利息支出(元) 25,172,000.0066,896,000.0038,736,000.0081,595,000.0021,802,000.00
 利息收入(元) -57,599,000.00-105,415,000.00-51,432,000.00-70,737,000.00-29,512,000.00
 存货的减少增加(元) -143,931,000.00-118,045,000.00-33,302,000.00-158,036,000.00-215,176,000.00
 应收帐款减少增加(元) 1,384,016,000.00-1,562,217,000.00--392,217,000.00-
 应付帐款增加减少(元) -1,261,956,000.00792,368,000.00747,957,000.00238,364,000.0045,549,000.00
 预收账款、按金及其他应付款增加减少(元) ---30,644,000.00--18,757,000.00
 经营资金变动其他项目(元) -23,980,000.00-43,782,000.00-1,160,912,000.0056,283,000.00-138,150,000.00
 经营活动产生的现金(元) 2,207,903,000.002,966,430,000.001,470,153,000.002,330,390,000.00806,708,000.00
 已付税项(元) -362,326,000.00-526,992,000.00-272,682,000.00-299,847,000.00-147,156,000.00
 经营活动产生的现金流量净额(元) 1,845,577,000.002,439,438,000.001,197,471,000.002,030,543,000.00659,552,000.00
投资活动产生的现金流量
 购买物业、厂房及设备支付的现金(元) -779,146,000.00-1,274,484,000.00-396,697,000.00-701,072,000.00-247,751,000.00
 出售物业、厂房及设备收到的现金(元) 1,684,000.004,367,000.002,248,000.007,586,000.00252,000.00
 购买无形资产及其他资产支付的现金(元) -38,605,000.00-187,451,000.00-495,000.00-38,911,000.00-25,513,000.00
 购买证券投资所支付的现金(元) -10,650,660,000.0072,748,000.00-3,188,296,000.0017,973,000.00-
 出售证券投资所收到的现金(元) 10,680,286,000.00-3,203,206,000.00--
 已收利息及股息投资(元) 57,599,000.00105,415,000.0051,432,000.0070,737,000.0029,512,000.00
 投资活动产生的现金流量净额其他项目(元) 205,172,000.00-277,545,000.00-52,956,000.0048,768,000.00117,973,000.00
 投资活动产生的现金流量净额(元) -523,670,000.00-1,556,950,000.00-381,558,000.00-594,919,000.00-125,527,000.00
融资活动产生的现金流量
 新增借款(元) 1,069,596,000.002,044,000,000.001,244,000,000.002,951,824,000.00861,357,000.00
 偿还借款(元) -127,000,000.00-2,778,755,000.00-2,030,355,000.00-2,623,646,000.00-631,358,000.00
 吸收投资所得(元) 35,999,000.0012,000,000.00-2,000,000.00-
 回购股份(元) ----42,291,000.00-40,689,000.00
 已付股息融资(元) --581,448,000.00--272,636,000.00-
 已付利息融资(元) -31,669,000.00-78,431,000.00-40,635,000.00-75,615,000.00-17,007,000.00
 融资活动产生的现金流量净额其他项目(元) 23,443,000.0019,956,000.0012,251,000.0036,198,000.00-555,000.00
 融资活动产生的现金流量净额(元) 970,369,000.00-1,362,678,000.00-814,739,000.00-24,166,000.00171,748,000.00
现金及现金等价物净增加额(元) 2,292,276,000.00-480,190,000.001,174,000.001,411,458,000.00705,773,000.00
现金及现金等价物的期初余额(元) 4,261,989,000.004,743,071,000.004,743,071,000.003,331,009,000.003,331,009,000.00
现金及现金等价物的期末余额其他项目(元) 565,000.00-892,000.00597,000.00604,000.001,174,000.00
现金及现金等价物的期末余额(元) 6,554,830,000.004,261,989,000.004,744,842,000.004,743,071,000.004,037,956,000.00
公告日期 2024-09-272024-04-292023-09-282023-04-272022-09-23
会计准则 香港会计准则香港会计准则香港会计准则香港会计准则香港会计准则
审计意见 -----
审核师 -----
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院